Pricing Log in Create free account

Adicet Bio, Inc. (ACET) vs Metagenomi Therapeutics, Inc. (MGX)

Adicet Bio, Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Adicet Bio, Inc. and Metagenomi Therapeutics, Inc. are of similar size ($27.6M and $27.3M). Adicet Bio, Inc. grew revenue faster over the last twelve months: 224.6% against −59.8%. Adicet Bio, Inc. has the higher net margin (0.00% vs −689.2%) and the lower return on invested capital (−2,518.2% vs 0.00%). Across the 18 metrics below, Adicet Bio, Inc. leads on 9 and Metagenomi Therapeutics, Inc. on 9.

Valuation

Metric ACET MGX Biotechnology median
P/E n/m n/m 10.60
P/S 0.85 1.94 9.40
P/B 0.27 0.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.84 0.66 0.66
EV/Sales (2.19) (4.72) 9.02
Earnings yield (375.41%) (355.71%) (32.88%)
Free cash flow yield (259.25%) (325.47%) (23.13%)

Profitability

Metric ACET MGX Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (741.58%) 0.00%
Net margin 0.00% (689.20%) 0.00%
Free cash flow margin 0.00% (632.67%) 0.00%
Return on equity (78.08%) (60.61%) (51.96%)
Return on assets (63.62%) (41.91%) (46.06%)
Return on invested capital (2,518.16%) 0.00% 0.00%

Growth

Metric ACET MGX Biotechnology median
Revenue growth (TTM) 224.62% (59.84%) 6.76%
EPS growth (last fiscal year) 20.35% 0.00% 29.88%
Revenue growth, 5-year CAGR 6.90% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACET MGX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 6.71 4.50 4.97
Net debt to EBITDA 1.32 1.71 1.01

Dividend

Metric ACET MGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACET MGX Biotechnology median
Market cap 27.33m 27.60m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack